David Liljenquist works in the field of Endocrinology. He attended George Washington University School of Medicine. George Washington University School of Medicine has a rank of 67 in research and a 0 in primary care He has 2 awards "Regional Top Doctor" and "CMS Meaningful Use Stage 1 Certification". David Liljenquist is a published doctor and has 1 publication published. The lastest was: 'Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome.' He accepts Medicare.
University of Chicago
Mayo School of Graduate Medical Education
George Washington University School of Medicine| NPI NUMBER | 1932109931 | |
| NPPES Provider LastName | LILJENQUIST | |
| NPPES Provider FirstName | DAVID | |
| NPPES Provider ZIPCode | 834047542 | |
| NPPES Provider State | ID | |
| Specialty Description | Endocrinology | |
| Total Claim Count | 18288.0 | |
| Distinct Opioid Count | 4.0 | |
| Opioid Claim Count | 439.0 | |
| Percent Opioid Claims | 2.4 |
| National Provider Identifier [NPI] | 1932109931 |
| Last Name Of The Provider | LILJENQUIST |
| First Name Of The Provider | DAVID |
| View All |
|
Dr. Carl D. Vance, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. John L. Seaich, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. John E. Liljenquist, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Laura M. Ferries, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|